Two Sigma Investments, LP Allogene Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $42.3 Billion
- Q3 2024
A detailed history of Two Sigma Investments, LP transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 2,797,970 shares of ALLO stock, worth $5.37 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,797,970
Previous 2,960,673
5.5%
Holding current value
$5.37 Million
Previous $6.9 Million
13.57%
% of portfolio
0.02%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding ALLO
# of Institutions
165Shares Held
134MCall Options Held
59.4KPut Options Held
113K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$35.9 Million1.25% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$31.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$16 Million0.0% of portfolio
-
State Street Corp Boston, MA7.01MShares$13.5 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.9MShares$13.2 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $276M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...